Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation

Thrombosis and Haemostasis

Volumn 109, Issue 6, 2013, Pages 1025-1032

  Tan, Xiaoyan ^a   Shi, Jialan ^a,b   Fu, Yueyue ^a   Gao, Chunyan ^a   Yang, Xue ^a   Li, Jianan ^a   Wang, Wei ^a   Hou, Jinxiao ^a   Li, Huibo ^a   Zhou, Jin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Lactadherin; Microparticles; Phosphatidylserine; Polycythaemia vera

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; HEMOGLOBIN; LACTADHERIN; PHOSPHATIDYLSERINE; THROMBIN; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HEMATOCRIT; HUMAN; HYPERCOAGULABILITY; MALE; MEMBRANE MICROPARTICLE; NEUTROPHIL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOSIS;

ADULT; AGED; ANTIGENS, SURFACE; BLOOD COAGULATION; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; COAGULANTS; CYSTEINE ENDOPEPTIDASES; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MILK PROTEINS; NEOPLASM PROTEINS; NEUTROPHILS; PHOSPHATIDYLSERINES; POLYCYTHEMIA VERA; THROMBOPLASTIN;

EID: 84878643718     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-11-0811     Document Type: Article

References (39)

1. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood 2002; 100: 4272-4290.
2. Landolfi R, Di Gennaro L, Falanga A. Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation. Leukemia 2008; 22: 2020-2028.
3. Sonmez M, Saglam F, Karahan SC, et al. Treatment related changes in antifibri-nolytic activity in patients with polycythemia vera. Haematology 2010; 15: 391-396.
4. Landolfi R, Di Gennaro L. Thrombosis in myeloproliferative and myelodys-plastic syndromes. Haematology 2012; 17 Suppl 1: S174-176.
5. Di Nisio M, Barbui T, Di Gennaro L, et al. The haematocrit and platelet target in polycythemia vera. Br J Haematol 2007; 136: 249-259.
6. Michiels JJ, Berneman Z, Schroyens W, et al. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombo-cythemia and polycythemia vera. Semin Thromb Hemost 2006; 32: 589-604.
7. Leventis PA, Grinstein S. The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 2010; 39: 407-427.
8. Yeung T, Gilbert GE, Shi J, et al. Membrane phosphatidylserine regulates surface charge and protein localisation. Science 2008; 319: 210-213.
9. Shi J, Shi Y, Waehrens LN, et al. Lactadherin detects early phosphatidylserine exposure on immortalised leukemia cells undergoing programmed cell death. Cytometry A 2006; 69: 1193-1201.
10. Morel O, Jesel L, Freyssinet JM, et al. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 15-26.
11. Montoro-Garcia S, Shantsila E, Marin F, et al. Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol 2011; 106: 911-923.
12. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102: 2678-2683.
13. Gao C, Xie R, Yu C, et al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb Haemost 2012; 107: 681-689.
14. Weiss E, Rees DC, Gibson JS. Role of calcium in phosphatidylserine externali-sation in red blood cells from sickle cell patients. Anemia 2011; 2011: 379894.
15. Tsimerman G, Roguin A, Bachar A, et al. Involvement of microparticles in diabetic vascular complications. Thromb Haemost 2011; 106: 310-321.
16. Presseizen K, Friedman Z, Shapiro H, et al. Phosphatidylserine Expression on the Platelet Membrane of Patients with Myeloproliferative Disorders and its Effect on Platelet-Dependent Thrombin Formation. Clin Appl Thromb Hemost 2002; 8: 33-39.
17. Fujita H, Sakuma R, Tomiyama J, et al. Increased phosphatidylserine exposure on the erythrocyte membrane in patients with polycythaemia vera. Br J Haema-tol 2011; 152: 238-240.
18. Shi J, Heegaard C W, Rasmussen JT, et al. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. Biochim Bio-phys Acta 2004; 1667: 82-90.
19. Hou J, Fu Y, Zhou J, et al. Lactadherin functions as a probe for phosphatidylser-ine exposure and as an anticoagulant in the study of stored platelets. Vox Sang 2011; 100: 187-195.
20. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood 2003; 101: 2628-2636.
21. Fu Y, Zhou J, Li H, et al. Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release. Thromb Haemost 2010; 104: 1235-1241.
22. Vardiman J W, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organisation (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937-951.
23. Hvarregaard J, Andersen MH, Berglund L, et al. Characterisation of glycopro-tein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem 1996; 240: 628-636.
24. Xie R, Gao C, Li W, et al. Phagocytosis by macrophages and endothelial cells inhibits procoagulant and fibrinolytic activity of acute promyelocytic leukemia cells. Blood 2012; 119: 2325-2334.
25. Mause SF, Weber C. Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange. Circ Res 2010; 107: 1047-1057.
26. Dignat-George F, Freyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets 2009; 20: 225-226.
27. Lacroix R, Robert S, Poncelet P, et al. Standardisation of platelet-derived micro-particle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J Thromb Haemost 2010; 8: 2571-2574.
28. Zhou J, Liu S, Ma M, et al. Procoagulant activity and phosphatidylserine of am-niotic fluid cells. Thromb Haemost 2009; 101: 845-851.
29. Duchemin J, Ugo V, Ianotto JC, et al. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms. Thromb Res 2010; 126: 238-242.
30. Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and poly-cythemia vera. Blood 2000; 96: 4261-4266.
31. Presti RL, Caracciolo C, Montana M, et al. Erythrocyte deformability evaluated by laser diffractometry in polycythemia vera. Clin Hemorheol Microcirc 2012; 50: 189-192.
32. Haynes J, Jr., Obiako B, Hester RB, et al. Hydroxyurea attenuates activated neut-rophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. Am J Physiol Heart Circ Physiol 2008; 294: H379-385.
33. Gerotziafas GT, Van Dreden P, Chaari M, et al. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb Haemost 2012; 107: 1044-1052.
34. Trappenburg MC, van Schilfgaarde M, Marchetti M, et al. Elevated procoagu-lant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 2009; 94: 911-918.
35. Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost 2010; 105: 396-408.
36. Suades R, Padró T, Vilahur G, et al. Circulating and platelet-derived micropar-ticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost 2012; 108: 1208-1219.
37. van Doormaal F, Kleinjan A, Berckmans RJ, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost 2012; 108: 160-165.
38. Auwerda JJ, Yuana Y, Osanto S, et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2011; 105: 14-20.
39. Osterud B. Tissue factor expression in blood cells. Thromb Res 2010; 125 (Suppl 1): S31-34.